Analysis of disease-free survival (DFS) showed a correlation between highly expressed LIFR and a worse prognosis for ACC, BLCA and STAD, although it was a protective factor for KIRC, PRAD and THCA (Figure 2B). Here, LIFR is linked to adrenal cortex carcinoma.